Early Clinical Complications After ABO-Incompatible Live-Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients

被引:76
作者
Lentine, Krista L. [1 ,2 ]
Axelrod, David [3 ]
Klein, Christina [4 ]
Simpkins, Christopher [3 ]
Xiao, Huiling [1 ]
Schnitzler, Mark A. [1 ,2 ]
Tuttle-Newhall, Janet E. [2 ]
Dharnidharka, Vikas R. [4 ]
Brennan, Daniel C. [4 ]
Segev, Dorry L. [5 ]
机构
[1] St Louis Univ, Ctr Outcomes Res, Sch Med, St Louis, MO 63104 USA
[2] St Louis Univ, Sch Med, Dept Surg, Div Abdominal Transplantat, St Louis, MO 63104 USA
[3] Dartmouth Hitchcock Med Ctr, Dept Surg, Div Abdominal Transplantat, Hanover, NH USA
[4] Washington Univ, Sch Med, St Louis, MO USA
[5] Johns Hopkins Univ, Dept Surg, Div Abdominal Transplantat, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
Blood group incompatibility; Hemorrhage; Infection; Kidney transplantation; Living donors; Medicare; ANTIGEN-SPECIFIC IMMUNOADSORPTION; RENAL-TRANSPLANTATION; UNITED-STATES; COAGULATION ABNORMALITIES; PAIRED DONATION; ACUTE REJECTION; GRAFT FAILURE; SPLENECTOMY; PLASMAPHERESIS; RITUXIMAB;
D O I
10.1097/TP.0000000000000029
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Descriptions of the sequelae of ABO-incompatible (ABOi) kidney transplantation are limited to single-center reports, which may lack power to detect important effects. Methods. We examined U. S. Renal Data System registry data to study associations of ABOi live-donor kidney transplantation with clinical complications in a national cohort. Among 14,041 Medicare-insured transplants in 2000 to 2007, 119 non-donor-A2 ABOi transplants were identified. A2-incompatible (n=35) transplants were categorized separately. Infection and hemorrhage events were identified by diagnosis codes on billing claims. Associations of ABO incompatibility with complications were assessed by multivariate Cox regression. Results. Recipients of ABOi transplants experienced significantly (P<0.05) higher incidence of wound infections (12.7% vs. 7.3%), pneumonia (7.6% vs. 3.8%), and urinary tract infections (UTIs) or pyelonephritis (24.5% vs. 15.3%) in the first 90 days compared with ABO-compatible recipients. In adjusted models, ABO incompatibility was associated with twice the risk of pneumonia (adjusted hazard ratio [aHR], 2.22; 95% confidence interval [CI], 1.14-4.33) and 56% higher risk of UTIs or pyelonephritis (aHR, 1.56; 95% CI, 1.05-2.30) in the first 90 posttransplantation days, and 3.5 times the relative risk of wound infections in days 91 to 365 (aHR, 3.55; 95% CI, 1.92-6.57). ABOi recipients, 19% of whom underwent pre- or peritransplant splenectomy, experienced twice the adjusted risk of early hemorrhage (aHR, 1.96; 95% CI, 1.19-3.24). A2-incompatible transplantation was associated only with early risk of UTIs or pyelonephritis. Conclusion. ABOi transplantation offers patients with potential live donors an additional transplant option but with higher risks of infectious and hemorrhagic complications. Awareness of these complications may help improve protocols for the management of ABOi transplantation.
引用
收藏
页码:54 / 65
页数:12
相关论文
共 39 条
[21]   Outcomes of ABO-Incompatible Kidney Transplantation in the United States [J].
Montgomery, John R. ;
Berger, Jonathan C. ;
Warren, Daniel S. ;
James, Nathan T. ;
Montgomery, Robert A. ;
Segev, Dorry L. .
TRANSPLANTATION, 2012, 93 (06) :603-609
[22]   ABO-Incompatible Kidney Transplantation Enabled by Non-Antigen-Specific Immunoadsorption [J].
Morath, Christian ;
Becker, Luis Eduardo ;
Leo, Albrecht ;
Beimler, Joerg ;
Klein, Katrin ;
Seckinger, Joerg ;
Kihm, Lars Philipp ;
Schemmer, Peter ;
Macher-Goeppinger, Stephan ;
Wahrmann, Markus ;
Boehmig, Georg A. ;
Opelz, Gerhard ;
Suesal, Caner ;
Zeier, Martin ;
Schwenger, Vedat .
TRANSPLANTATION, 2012, 93 (08) :827-834
[23]   The effectiveness of intravenous human immunoglobulin treatment after plasmapheresis in restoring serum immunoglobulin levels: A preliminary study [J].
Moriya, Y ;
Yamaji, K ;
Kanai, Y ;
Tsuda, H .
THERAPEUTIC APHERESIS, 2002, 6 (02) :154-158
[24]  
OPTN (Organ Procurement and Transplantation Network)/UNOS (United Network for Organ Sharing), NAT DAT REP
[25]   Underutilization of A2 ABO incompatible kidney transplantation [J].
Redfield, Robert R. ;
Parsons, Ronald F. ;
Rodriguez, Eduardo ;
Mustafa, Moiz ;
Cassuto, James ;
Vivek, Kumar ;
Noorchashm, Hooman ;
Naji, Ali ;
Levine, Matthew H. ;
Abt, Peter L. .
CLINICAL TRANSPLANTATION, 2012, 26 (03) :489-494
[26]   Postoperative Bleeding after ABO-incompatible Living Donor Kidney Transplantation [J].
Renner, F. C. ;
Czekalinska, B. ;
Kemkes-Matthes, B. ;
Feustel, A. ;
Stertmann, W. A. ;
Padberg, W. ;
Weimer, R. .
TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) :4164-4166
[27]   Bleeding complications in pediatric ABO-incompatible kidney transplantation [J].
Schaefer, Betti ;
Toenshoff, Burkhard ;
Schmidt, Jan ;
Golriz, Mohammad ;
Mehrabi, Arianeb ;
Gombos, Petra ;
Morath, Christian ;
Wuehl, Elke ;
Schaefer, Franz ;
Schmitt, Claus Peter .
PEDIATRIC NEPHROLOGY, 2013, 28 (02) :327-332
[28]  
Schnitzler Mark A, 2013, J Med Econ, V16, P75, DOI 10.3111/13696998.2012.722571
[29]   Renal function following living, standard criteria deceased and expanded criteria deceased donor kidney transplantation: impact on graft failure and death [J].
Schnitzler, Mark A. ;
Lentine, Krista L. ;
Gheorghian, Adrian ;
Axelrod, David ;
Trivedi, Digisha ;
L'Italien, Gilbert .
TRANSPLANT INTERNATIONAL, 2012, 25 (02) :179-191
[30]   Complications, resource utilization, and cost of ABO-incompatible living donor kidney transplantation [J].
Schwartz, Jason ;
Stegall, Mark D. ;
Kremers, Walter K. ;
Gloor, James .
TRANSPLANTATION, 2006, 82 (02) :155-163